A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Public ClinicalTrials.gov record NCT02498665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I Clinical Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Study identification
- NCT ID
- NCT02498665
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- DSP-7888 Dosing Emulsion Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2015
- Primary completion
- Jul 31, 2018
- Completion
- Aug 31, 2018
- Last update posted
- Nov 13, 2023
2015 – 2018
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USOR - Rocky Mountain Cancer Center | Denver | Colorado | 80218 | — |
| Emory University Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Horizon Oncology Research | Lafayette | Indiana | 47905 | — |
| USOR - TX Oncology Austin | Austin | Texas | 78705 | — |
| USOR -TX Oncology Dallas | Dallas | Texas | 75246 | — |
| USOR - TX Oncology Tyler | Tyler | Texas | 75702 | — |
| USOR - VA Cancer Specialists | Fairfax | Virginia | 22031 | — |
| USOR - VA Oncology Associates | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02498665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2023 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02498665 live on ClinicalTrials.gov.